As COVID-19 sweeps across the earth, life sciences companies are rushing to find ways to diagnose, prevent and treat the virus. They face legal challenges—from regulatory oversight to supply chain disruption and product liability. How do these global innovators handle their legal risks as they rush to solve this puzzle? Listen to the podcast here or download a transcript of the conversation.

Download Attachment

See all Member News